What is the evidence from RCTs of high-risk individuals from the general population for ARBs and ACE-Is?
There is high-quality evidence from trials of high-risk individuals from the general population showing that ARBs and ACE-Is improve cardiovascular outcomes,185,271 276 including in patients with diabetes.277,278 But these studies did not focus on patients with clinically significant albuminuria.